Alpha, beta, theta: what are brain states and brain waves? And can we control them? 
The rising flood of space junk is a risk to us on Earth – and governments are on the hook 
Archeoastronomy uses the rare times and places of previous total solar eclipses to help us measure history 
Why now is the time to address humanity’s impact on the moon 
If life exists on Jupiter’s moon Europa, scientists might soon be able to detect it 
What is minoxidil, the anti-balding hair growth treatment? Here’s what the science says 
Six space missions to look forward to in 2024 
Could a telescope ever see the beginning of time? An astronomer explains 
Why some people don't trust science – and how to change their minds 
Synthetic human embryos let researchers study early development while sidestepping ethical and logistical hurdles 
Customizing mRNA is easy, and that's what makes it the next frontier for personalized medicine − a molecular biologist explains 
Dark energy is one of the biggest puzzles in science and we're now a step closer to understanding it 
How do airplanes fly? An aerospace engineer explains the physics of flight 
Tatahouine: 'Star Wars meteorite' sheds light on the early Solar System 
The search for the cure for cancer continues in different parts of the world. Recently, a group of scientists from Israel announced they could come up with a fully-tested remedy within a year. However, other experts are doubting that timetable is achievable.
Accelerated Evolution Biotechnologies Ltd. (AEBi) board chairman Dan Aridor told the Jerusalem Post earlier this week, “We believe we will offer in a year’s time a complete cure for cancer.” Aridor refers to the cancer cure they are developing as MuTaTo or multi-target toxin that reportedly acts like a cancer antibiotic.
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects,” Aridor added. He also promised that they intend to make it accessible by pricing it “at a much lower cost than most other treatments on the market.”
At the time of the report, the company confirmed that the cancer cure they are working on has passed the “first exploratory mice experiment.” The publication of the research suggests that scientists are seeing positive results so far.
However, other experts in the field are doubtful that the cure would be ready within a year as mentioned. The news of a possible cancer cure is a great one, however, Dr. Benjamin G. Neel of the NYU School of Medicine said the Israeli company’s own statement is what makes him “doubt” they can get it out in a year.
Neel, who is also the Director of the Laura and Isaac Perlmutter Cancer Center, told Forbes, “Apparently, the work has only been done in mice. Anything tested in mice has to undergo testing in other animal species, be formulated, and then approved to administration in Phase I clinical trials in humans.” AEBi later clarified to CNBC that the time frame they mentioned meant they are looking forward to having “the complete solution ready” by the time tests on humans are about to be carried out.
